Genentech

Curis Earns $8 Million Milestone As NDA Accepted By FDA
Seeking Alpha
Thu, 11/10/11 - 01:08 pm
Curis
milestone payments
FDA
basal cell carcinoma
Genentech
vismodegib
Micromet Unveils Another Fast Route To Market, Marks Pfizer As Lead Competitor
Seeking Alpha
Sun, 10/16/11 - 07:05 pm
Micromet
Pfizer
blinatumomab
acute lymphoblastic leukemia
leukemia
Bmab
SAR3419
Sanofi
inotuzumab
Genentech
Seattle Genetics
Doctors Grow Wary of Avastin for Eye Treatment
NY Times, NY
Wed, 10/5/11 - 10:55 am
Genentech
Avastin
Lucentis
New label on Genentech's Avastin warns of infertility
Bizjournals.com
Wed, 10/5/11 - 10:50 am
Avastin
Infertility
warnings
Genentech
Insurer Won’t Pay For Avastin Breast Cancer Use
Pharmalot
Mon, 10/3/11 - 11:03 am
breast cancer
Avastin
insurance
Genentech
Off-Label Avastin Use, Medicare And Saving Money
Pharmalot
Wed, 09/7/11 - 09:54 am
Medicare
off-label
Avastin
Roche
Genentech
age-related macular degeneration
Off-Label Avastin Injections Linked To Blindness
Pharmalot
Wed, 08/31/11 - 09:31 am
off-label
blindness
Avastin
Genentech
Roche
Galapagos gains third extension of Genentech deal in $35M pact
Fierce Biotech
Thu, 08/18/11 - 02:17 pm
Genentech
Galapagos
Argenta
Array BioPharma lands Genentech drug-development deal
Bizjournals.com
Tue, 08/9/11 - 10:07 am
drug development
Array Biopharma
Genentech
Genentech pitches Avastin compromise to FDA
Fierce Pharma
Mon, 08/8/11 - 12:39 pm
FDA
breast cancer
Avastin
Genentech
PDL climbs 8% on patent case ruling
Marketwatch
Mon, 07/11/11 - 12:33 pm
PDL Biopharma
patents
Roche
Genentech
Avastin
Herceptin
Lucentis
Xolair
Genentech, Once Known For Innovation, Is Pursuing A Nexium Strategy With Lucentis
Forbes
Sat, 04/30/11 - 10:07 am
Genentech
Lucentis
macular degeneration
Roche's Genentech Sues Novartis Unit Claiming Infringement of Valcyte Drug
Bloomberg
Thu, 04/21/11 - 09:23 am
Genentech
Novartis
Valcyte
generics
patents
AIDS
FDA approves Genentech vasculitis treatment
Bizjournals.com
Wed, 04/20/11 - 12:04 pm
FDA
Genentech
vasculitis
Rituxan
10 promising late-stage cancer drugs
Fierce Biotech
Tue, 04/5/11 - 10:47 pm
cancer
Carfilzomib
crizotinib
vismodegib
Oncovex
PLX4032
Ponatinib
SGN-35
tivozanib
T-DM1
cabozantinib
ONYX Pharmaceuticals
Pfizer
Genentech
Curis
Amgen
Plexxikon
Seattle Genetics
Ariad Pharmaceuticals
Aveo Pharmaceutical
Exelixis
Roche
Pfizer, Genentech and APP initiate recalls
Fierce Pharma
Mon, 03/28/11 - 11:45 am
recalls
Pfizer
Genentech
APP
Which Sales Reps Rank Highest With Oncologists?
Pharmalot
Tue, 02/22/11 - 10:36 am
drug reps
oncologists
Roche
Genentech
Novartis
Genentech's Lucentis does well in study of diabetic eye condition Read more: Genentech's Lucentis does well in study of diabetic eye condition
bizjournals.com
Sat, 02/12/11 - 12:23 pm
Lucentis
Genentech
diabetic macular edema
diabetes
Genentech cites chemo comparisons in Avastin appeal
Fierce Pharma
Wed, 01/19/11 - 11:16 am
Avastin
Roche
Genentech
FDA
breast cancer
Roche, Avastin And An Influential Cancer Doc Panel
Pharmalot
Tue, 01/11/11 - 02:41 pm
Avastin
Roche
Genentech
FDA
breast cancer

Pages